← Leaderboards
Elizabeth T Jacobs
University Of Arizona
$4,207,163
Attributed
$4,962,979
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $521.7K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,962,979 · 5
By mechanism
R01$4,185,953 · 3
K07$664,706 · 1
R03$112,320 · 1
Top collaborators
- Peter W Jurutka5 shared
Most similar at University Of Arizona
Same institution · by research overlap
- M. Peter Lance$14,378,762
- Eugene W Gerner$5,028,555
- Fred Kadlubar$724,236
- Peter W Jurutka$997,900
- Mark R Haussler$5,690,149
Others in their field
Top investigators on “Recurrence”
- Philip J Disaia · University Of California Irvine$95,481,777
- David Heimbrook · Leidos Biomedical Research, Inc.$87,033,539
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
- Myron S Cohen · Family Health International$84,793,830
- Lawrence Corey · Fred Hutchinson Cancer Center$59,594,035
- Dan H. Barouch · Fred Hutchinson Cancer Center$59,594,035
Research focus
RecurrenceColorectal NeoplasmsAdenomaColorectal CancerVariantColorectal AdenomaInvestigationParticipantDesignVitamin DIntakeEpidemiologyAttentionCarcinogenesisChemopreventive AgentClinical TrialsDietary SupplementsBaseIncidenceAreaHormonesColorectalCancer PreventionCohort
Grant awards (20)
Selenium Chemoprevention: Benefits and Harms$364,547
R01 · FY2021 · CA · contact PI
Selenium Chemoprevention: Benefits and Harms$364,639
R01 · FY2020 · CA · contact PI
Selenium Chemoprevention: Benefits and Harms$437,924
R01 · FY2019 · CA · contact PI
Selenium Chemoprevention: Benefits and Harms$500,728
R01 · FY2018 · CA · contact PI
Selenium Chemoprevention: Benefits and Harms$372,191
R01 · FY2017 · CA · contact PI
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri$294,192
R01 · FY2014 · CA · contact PI
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri$285,146
R01 · FY2013 · CA · contact PI
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri$303,381
R01 · FY2012 · CA · contact PI
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri$303,435
R01 · FY2011 · CA · contact PI
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and Ri$325,479
R01 · FY2010 · CA · contact PI
Serum 25(OH)D, Vitamin D Intake, and Breast Cancer Recurrence in the WHEL Study$196,177
R01 · FY2010 · CA · contact PI
Serum 25(OH)D, Vitamin D Intake, and Breast Cancer Recurrence in the WHEL Study$229,080
R01 · FY2009 · CA · contact PI
VDR Variants, Nutrient Intakes, and Adenoma Recurrence$134,115
K07 · FY2009 · CA · contact PI
Serum 25(OH)D, Vitamin D Intake, and Breast Cancer Recurrence in the WHEL Study$209,034
R01 · FY2008 · CA · contact PI
VDR Variants, Nutrient Intakes, and Adenoma Recurrence$134,115
K07 · FY2008 · CA · contact PI
VDR Variants, Nutrient Intakes, and Adenoma Recurrence$134,115
K07 · FY2007 · CA · contact PI
VDR Variants, Nutrient Intakes, and Adenoma Recurrence$132,640
K07 · FY2006 · CA · contact PI
VDR Variants, Nutrient Intakes, and Adenoma Recurrence$129,721
K07 · FY2005 · CA
Fiber and Colorectal Adenomas: A Pooling Project$48,303
R03 · FY2005 · CA
Fiber and Colorectal Adenomas: A Pooling Project$64,017
R03 · FY2004 · CA